Clinical Trials Browser

Interventional × Nasopharyngeal Neoplasms × 30 days × Clear all

NCT07524413 2026-04-13

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Not yet recruiting

Nasopharyngeal Neoplasms

NCT06457503 2026-04-06

TRANSPARENT

Phase 4 Recruiting

Nasopharyngeal Neoplasms